Annual bioProcessUK Conference 2018

Monday November 12th, 2018 | Events, General

Meet us at the Annual bioProcessUK Conference 2018! The BIA is organizing the 15th Annual bioProcessUK Conference that is taking place in Edinburgh on 20-22 November 2018. The conference goes from strength to strength and 2017 saw over 285 delegates from 160 leading organisations attend to hear the latest news/updates and developments within the manufacturing […]

Spanish Biotech Industry: 3P selected as one of the Main Success Stories

Wednesday October 31st, 2018 | General

3P Biopharmaceuticals has been selected as one of the Main Success Stories in the Spanish biotech sector in the last 10 years. ASEBIO presented last week this report where are described a total of 20 success cases of the Biotechnology Sector in Spain in the last 10 years. These success stories have been carefully selected […]

“ambr15 for cell culture process optimization” Webinar 3P Biopharmaceuticals and Sartorius Stedim Biotech

Monday July 16th, 2018 | General

“ambr15 for cell culture process optimization” Webinar 3P Biopharmaceuticals and Sartorius Stedim Biotech Did you miss our webinar about our experience using ambr® 15 with CHO-S cell line for the production of monoclonal antibodies? Watch it now! What will you learn? High-throughput media and feed screening for cell culture process optimization with multi-parallel micro bioreactors […]

3P Biopharmaceuticals incorporates a LIMS, a Laboratory Information Management Systems

Monday June 25th, 2018 | General

3P Biopharmaceuticals is incorporating a new Laboratory Information Management Systems (LIMS) from Abbott Informatics, a global leader provider of laboratory solutions. The implementation phase is currently in progress together with Abbott Informatics who are also ensuring the specific training required for the completion of each milestone. LIMS is a comprehensive solution that improves quality and […]

3P Biopharmaceuticals and Viscofan to collaborate in an innovate advanced therapy project

| General

Cardiomesh is the project in which 3P Biopharmaceuticals and Viscofan are collaborating to develop and manufacture an innovative cell therapy product. 3P Biopharmaceuticals has executed the tuning, the process validation and the GMP manufacturing for clinical use. 3P Biopharmaceuticals, a CDMO specialized in the process development and GMP manufacturing of biologics and cell therapy products, […]